Clancy, J., Rowe, S. M., Accurso, F. J., Aitken, M. L., Amin, R. S., Ashlock, M. A., . . . Konstan, M. W. (2011). Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

Clancy, JP, et al. Results of a Phase IIa Study of VX-809, an Investigational CFTR Corrector Compound, in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation. 2011.

Clancy, JP, et al. Results of a Phase IIa Study of VX-809, an Investigational CFTR Corrector Compound, in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation. 2011.